Demonstration of mRNA using digoxigenin labelled oligonucleotide probes for in situ hybridisation in formamide free conditions.
Open Access
- 1 February 1993
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 46 (2) , 171-174
- https://doi.org/10.1136/jcp.46.2.171
Abstract
The value of formamide for use in in situ hybridisation (ISH) for the detection of mRNA, using either single or multi probe cocktails of digoxigenin labelled oligoprobes, was investigated. Three peptides with cell specific localisation in three separate tissues--calcitonin in the thyroid, epidermal growth factor (EGF) in the submaxillary gland, and insulin in the pancreas were studied. In each case localisation was confined to the appropriate cell type, but in the presence of formamide higher concentrations of probe and a longer development time were required. The abolition of formamide from the protocol for ISH makes the technique safer, cheaper, faster and more suitable for routine diagnostic use.Keywords
This publication has 4 references indexed in Scilit:
- Detection of mRNA by in situ hybridisation and in northern blot analysis using oligodeoxynucleotide probes labelled with alkaline phosphatase.Journal of Clinical Pathology, 1992
- Co-localization of EGF transcripts and peptides by combined immunohistochemistry and in situ hybridization.Journal of Histochemistry & Cytochemistry, 1990
- In situ hybridization of immunoglobulin light chain mRNA in paraffin sections using biotinylated or hapten‐labelled oligonucleotide probesThe Journal of Pathology, 1990
- Detection of messenger RNA using a digoxigenin end labelled oligodeoxynucleotide probe.Journal of Clinical Pathology, 1990